Orthocell Stock Quote OCC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.575

Bid

1.565

Ask

1.575

Volume

2,110,832

1.48 Day's Range 1.58

0.35 52 Week Range 1.66

Market Cap

329.69M

Previous Close

1.475

Open

1.505

Last Trade

805741

1.57

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,712,018

Shares Outstanding

209,326,818

Dividend Yield

PE Ratio

-45.77

Earnings Per Share (EPS)

-0.03

Revenue

5.73M

Net Profit

-7.18M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.orthocell.com.au

Headquarters

Perth, Western Australia, Aus

Founded

Orthocell Limited is listed in the Coml Physical, Biologcl Resh sector of the Australian Stock Exchange with ticker OCC. The last closing price for Orthocell was AUD1.48. Over the last year, Orthocell shares have traded in a share price range of AUD 0.35 to AUD 1.66.

Orthocell currently has 209,326,818 shares outstanding. The market capitalization of Orthocell is AUD308.76 million. Orthocell has a price to earnings ratio (PE ratio) of -45.77.

Orthocell Receives US Market Clearance

Australian-based regenerative medicine company, Orthocell Ltd, has received US 510k clearance to market and supply its collagen medical device for dental bone and tissue regeneration procedures...

Positive Pre-Clinical Results Using CelGro® in Anterior Cruciate Ligament (ACL) Reconstruction

Orthocell successfully conducted a pre-clinical evaluation using CelGro® collagen rope to replace the need for an autologous tendon graft for ACL reconstruction Study showed host...

Orthocell Secures New Patent for Suture-Less Repair of Soft Tissue

Australian patent granted for CelGro® soft tissue reconstruction platform, which covers the method of suture-less repair of soft tissue defects Suture-free repair of soft tissue has...

Orthocell Granted European Tendon Regeneration Patent

The European Patent Office has granted a patent entitled ‘Culture medium, culturing method and use of tenocytes’ Patent covers the method of manufacturing tendon regeneration cells...

Orthocell Commences Treatment of Its 1,000th Patient

Orthocell commences treatment of its 1,000th patient from its TGA licensed facility Underpins the extensive clinical validation of Orthocell’s revenue-stage Ortho-ATI® and Ortho-ACI®...

Orthocell obtient le marquage CE pour CelGro®

Approuvé pour le marketing et la distribution dans l’UE pour la régénération des tissus mous et osseux dentaires Premier produit d’une gamme diverse de dispositifs médicaux à base de...

Orthocell Receives CE Mark for CelGro®

Approved for marketing and distribution in EU for dental bone and soft tissue regeneration First product of a diverse suite of collagen medical devices to be commercialised from...

Orthocell Appoints Surgical Specialties as Exclusive Distributor

Surgical Specialties appointed as exclusive distributor in Australia and New Zealand of Orthocell’s world leading tendon regeneration (Ortho-ATI®) and cartilage regeneration therapy...

1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study

1st patient treated in clinical trial comparing Orthocell’s tendon regeneration therapy (Ortho-ATI®) to corticosteroids Trial undertaken in collaboration with DePuy Synthes Products...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.04	2.60586319218	1.535	1.635	1.455	1538715	1.57493999	DE
4	0.215	15.8088235294	1.36	1.66	1.22	2082248	1.40631397	DE
12	0.93	144.186046512	0.645	1.66	0.61	1712018	1.16895281	DE
26	1.19	309.090909091	0.385	1.66	0.3625	1041056	1.00414778	DE
52	1.18	298.734177215	0.395	1.66	0.35	597266	0.93101004	DE
156	1.145	266.279069767	0.43	1.66	0.3	307996	0.74451282	DE
260	1.115	242.391304348	0.46	1.66	0.18	402359	0.57884754	DE

OCC - Frequently Asked Questions (FAQ)

What is the current Orthocell share price?

The current share price of Orthocell is AUD 1.575

How many Orthocell shares are in issue?

Orthocell has 209,326,818 shares in issue

What is the market cap of Orthocell?

The market capitalisation of Orthocell is AUD 308.76M

What is the 1 year trading range for Orthocell share price?

Orthocell has traded in the range of AUD 0.35 to AUD 1.66 during the past year

What is the PE ratio of Orthocell?

The price to earnings ratio of Orthocell is -45.77

What is the cash to sales ratio of Orthocell?

The cash to sales ratio of Orthocell is 57.3

What is the reporting currency for Orthocell?

Orthocell reports financial results in AUD

What is the latest annual turnover for Orthocell?

The latest annual turnover of Orthocell is AUD 5.73M

What is the latest annual profit for Orthocell?

The latest annual profit of Orthocell is AUD -7.18M

What is the registered address of Orthocell?

The registered address for Orthocell is BUILDING 191, MURDOCH UNIVERSITY, SOUTH STREET, PERTH, WESTERN AUSTRALIA, 6150

What is the Orthocell website address?

The website address for Orthocell is www.orthocell.com.au

Which industry sector does Orthocell operate in?

Orthocell operates in the COML PHYSICAL, BIOLOGCL RESH sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CR3ODCore Energy Minerals Ltd	AUD 0.003 (200.00%)	3.57M
NAGONagambie Resources Limited	AUD 0.002 (100.00%)	550k
NRZONeuRizer Ltd	AUD 0.003 (50.00%)	6.13k
EELENRG Elements Ltd	AUD 0.0015 (50.00%)	21.49k
MVPMedical Developments International Limited	AUD 0.645 (48.28%)	1.42M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
BDTBirdDog Technology Ltd	AUD 0.037 (-33.93%)	7.86M
NRZNeuRizer Ltd	AUD 0.002 (-33.33%)	5.92M
MGUOMagnum Mining and Exploration Ltd	AUD 0.002 (-33.33%)	1.14M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
VAUVault Minerals Ltd	AUD 0.385 (5.48%)	49.45M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
SYASayona Mining Limited	AUD 0.023 (4.55%)	42.72M
LOTLotus Resources Limited	AUD 0.25 (6.38%)	42.53M